Companies / Kura Oncology, Inc. / Activity

Activity — Kura Oncology, Inc.

34 moves.

Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
InsidersInstitutions
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 2, 2026Bair Teresa Brophy
Executive
GrantCommon Stock$0+50K
+26.58%
238,139
0.27% of shares
low
Jan 2, 2026Ford Kathleen
Executive
GrantCommon Stock$0+50K
+47.45%
155,373
0.17% of shares
low
Jan 2, 2026Leoni Mollie
Executive
GrantCommon Stock$0+50K
+22.18%
275,454
0.31% of shares
low
Jan 2, 2026Doyle Thomas James
Executive
GrantCommon Stock$0+21K
+16.21%
152,309
0.17% of shares
low
Jan 2, 2026Powl Brian T.
Executive
GrantCommon Stock$0+50K
+35.79%
189,689
0.21% of shares
low
Jan 27, 2026Doyle Thomas James
Executive
SellCommon Stock$5.9K-695
-0.47%
148,274
0.17% of shares
low
Jan 27, 2026Doyle Thomas James
Executive
SellCommon Stock$7.5K-881
-0.60%
145,167
0.16% of shares
low
Jan 27, 2026Leoni Mollie
Executive
SellCommon Stock$8.0K-951
-0.35%
268,615
0.30% of shares
low
Jan 27, 2026Doyle Thomas James
Executive
SellCommon Stock$9.4K-1K
-0.74%
148,969
0.17% of shares
low
Jan 27, 2026Burrows Francis
Executive
SellCommon Stock$11.1K-1K
-3.89%
32,424
0.04% of shares
low
Jan 27, 2026Leoni Mollie
Executive
SellCommon Stock$11.3K-1K
-0.50%
267,274
0.30% of shares
low
Jan 27, 2026Powl Brian T.
Executive
SellCommon Stock$13.3K-2K
-0.85%
183,275
0.21% of shares
low
Jan 27, 2026Ford Kathleen
Executive
SellCommon Stock$15.3K-2K
-1.17%
153,560
0.17% of shares
low
Jan 27, 2026Doyle Thomas James
Executive
SellCommon Stock$18.8K-2K
-1.50%
146,048
0.16% of shares
low
Jan 27, 2026Doyle Thomas James
Executive
SellCommon Stock$18.8K-2K
-1.46%
150,083
0.17% of shares
low
Jan 27, 2026Leoni Mollie
Executive
SellCommon Stock$18.9K-2K
-0.82%
269,566
0.30% of shares
low
Jan 27, 2026Bair Teresa Brophy
Executive
SellCommon Stock$19.8K-2K
-1.00%
231,708
0.26% of shares
low
Jan 27, 2026Leoni Mollie
Executive
SellCommon Stock$30.9K-4K
-1.33%
271,799
0.31% of shares
low
Mar 18, 2026Malley Thomas
Director
ExerciseCommon Stock$31.2K+10K
10,000
0.01% of shares
low
Jan 27, 2026Bair Teresa Brophy
Executive
SellCommon Stock$34.7K-4K
-1.72%
234,043
0.26% of shares
low
Mar 23, 2026Wilson Troy Edward
CEO
ExerciseCommon Stock$37.5K+6K
+1.42%
435,456
0.49% of shares
low
Jan 27, 2026Bair Teresa Brophy
Executive
SellCommon Stock$40.4K-5K
-2.06%
226,931
0.26% of shares
low
Jan 27, 2026Powl Brian T.
Executive
SellCommon Stock$41.0K-5K
-2.55%
184,847
0.21% of shares
low
Jun 4, 2026Hasnain Faheem
Director
GrantOption to purchase common stock—+35K
35,000
0.04% of shares
low
Jun 4, 2026Schafer Carol
Director
GrantOption to purchase common stock—+35K
35,000
0.04% of shares
low
Jan 2, 2026Bair Teresa Brophy
Executive
GrantOption to purchase common stock—+100K
100,000
0.11% of shares
low
Jan 2, 2026Ford Kathleen
Executive
GrantOption to purchase common stock—+100K
100,000
0.11% of shares
low
Mar 23, 2026Wilson Troy Edward
CEO
ExerciseStock Option (Right to Buy)—+6K
0
0.00% of shares
low
Jan 2, 2026Wilson Troy Edward
CEO
GrantOption to purchase common stock—+1.1M
1,120,000
1.26% of shares
low
Mar 18, 2026Malley Thomas
Director
ExerciseStock Option (Right to Buy)—+10K
0
0.00% of shares
low
Jan 2, 2026Leoni Mollie
Executive
GrantOption to purchase common stock—+100K
100,000
0.11% of shares
low
Jan 2, 2026Doyle Thomas James
Executive
GrantOption to purchase common stock—+43K
42,500
0.05% of shares
low
Jan 2, 2026Burrows Francis
Executive
GrantOption to purchase common stock—+185K
185,000
0.21% of shares
low
Jan 2, 2026Powl Brian T.
Executive
GrantOption to purchase common stock—+100K
100,000
0.11% of shares
low
← PrevPage 1 of 1Next →